FORWARD FEATURES CALENDAR

Intelligence

Gide acts for ENYO Pharma on EUR40 million Series B funding round

Gide has advised ENYO Pharma on its EUR40 million Series B round of financing from US and European investors. ENYO Pharma is a clinical stage biotech company developing innovative drug candidates by mimicking virus strategies to modulate host cellular functions. This very significant funding will enable the company to finance

GCM Grosvenor adds to labour impact infrastructure team

GCM Grosvenor, a global alternative asset management firm with more than USD50 billion of assets under management, has appointed Matthew Rinklin as Managing Director. Rinklin joins GCM Grosvenor from Oaktree Capital Management and will be responsible for executing the firm’s Labour Impact Infrastructure investing strategy. Labour Impact Infrastructure investing is investment

Target Global launches dedicated mobility fund

Target Global, a Berlin-based international venture capital fund with USD600m in assets under management, is launching a dedicated fund to invest in next-generation mobility and transportation. Its unique evergreen structure means that, unlike traditional VC funds which have a fixed end-point, this one will run indefinitely. The fund can deploy

Portfolia launches ‘FemTech’ Fund

Venture investing platform Portfolia Funds has launched its sixth fund – The Portfolia FemTech Fund – which will invest exclusively in emerging technologies, products and services focused on improving women’s health and wellness. Frost and Sullivan recently published a report stating that FemTech will be a USD50 billion market by

Marqeta raises additional USD45m in funding led by ICONIQ Capital

Marqeta, an open-API card issuing platform, has raised USD45 million in new funding in a round led by ICONIQ Capital, with participation from Goldman Sachs and existing investors, bringing the firm’s total funding to USD116 million. “Marqeta is the clear market leader in modern card issuing, and we’re thrilled to

Linden invests in Solara Medical Supplies

Linden Capital Partners (Linden), a Chicago-based healthcare private equity firm, has completed its investment in Solara Medical Supplies. Headquartered in Chula Vista, California, Solara is a leading direct-to-patient supplier of advanced diabetic devices, including continuous glucose monitors, insulin pumps and other supplies for the intensively managed diabetic. Linden Operating Partner,

Announcement

Ropes & Gray advises Hamilton Lane on Strategic Opportunities Fund IV

Ropes & Gray has advised Hamilton Lane on Hamilton Lane Strategic Opportunities Fund IV. The Fund announced its final close with USD900 million in commitments on 5 June, substantially above the initial target. The Fund is focused on making credit-oriented investments with consistent cash yield, shorter duration and attractive risk-adjusted

Alan Halfenger, Optima

Former Bain Capital chief compliance officer joins Optima Partners

Regulatory compliance firm Optima Partners has appointed former Bain Capital chief compliance office Alan K Halfenger as a Partner at the firm. In his role at Optima, Halfenger (pictured) will focus on the regulatory and compliance needs of private equity managers, hedge funds, broker-dealers and global financial services firms.  Optima

HgCapital sells Intelliflo to Invesco

Intelliflo, a UK technology platform for financial advisers, has been acquired by Invesco. Intelliflo has been owned by HgCapital, a European private equity investor in B2B technology companies, since 2013. Since its inception in 2004, Intelliflo has experienced rapid growth and has become the No1 technology platform for financial advisers

Events

12 November, 2026 – 5:00 pm

Directory Listings